Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1993 Feb;35(2):93–104. doi: 10.1111/j.1365-2125.1993.tb05674.x

Treatment of vasculitis.

H G Taylor 1, A Samanta 1
PMCID: PMC1381499  PMID: 8443041

Full text

PDF
93

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aktulga E., Altaç M., Müftüoglu A., Ozyazgan Y., Pazarli H., Tüzün Y., Yalçin B., Yazici H., Yurdakul S. A double blind study of colchicine in Behçet's disease. Haematologica. 1980 Jun;65(3):399–402. [PubMed] [Google Scholar]
  2. Al-Safi S. A., Maddocks J. L. Azathioprine and 6-mercaptopurine (6-MP) suppress the human mixed lymphocyte reaction (MLR) by different mechanisms. Br J Clin Pharmacol. 1984 Apr;17(4):417–422. doi: 10.1111/j.1365-2125.1984.tb02366.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Al-Safi S. A., Maddocks J. L. Effects of azathioprine on the human mixed lymphocyte reaction (MLR). Br J Clin Pharmacol. 1983 Feb;15(2):203–209. doi: 10.1111/j.1365-2125.1983.tb01487.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Alarcón-Segovia D. The necrotizing vasculitides. A new pathogenetic classification. Med Clin North Am. 1977 Mar;61(2):241–260. doi: 10.1016/s0025-7125(16)31330-x. [DOI] [PubMed] [Google Scholar]
  5. Allison M. C., Gallagher P. J. Temporal artery biopsy and corticosteroid treatment. Ann Rheum Dis. 1984 Jun;43(3):416–417. doi: 10.1136/ard.43.3.416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Andersson R., Rundgren A., Rosengren K., Bengtsson B. A., Malmvall B. E., Mellström D. Osteoporosis after long-term corticosteroid treatment of giant cell arteritis. J Intern Med. 1990 Jun;227(6):391–395. doi: 10.1111/j.1365-2796.1990.tb00177.x. [DOI] [PubMed] [Google Scholar]
  7. Asherson R. A., D'Cruz D., Stephens C. J., McKee P. H., Hughes G. R. Urticarial vasculitis in a connective tissue disease clinic: patterns, presentations, and treatment. Semin Arthritis Rheum. 1991 Apr;20(5):285–296. doi: 10.1016/0049-0172(91)90029-y. [DOI] [PubMed] [Google Scholar]
  8. Austin H. A., 3rd, Klippel J. H., Balow J. E., le Riche N. G., Steinberg A. D., Plotz P. H., Decker J. L. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med. 1986 Mar 6;314(10):614–619. doi: 10.1056/NEJM198603063141004. [DOI] [PubMed] [Google Scholar]
  9. Axelson J. A., Clark R. H., Ancerewicz S. Wegener granulomatosis and trimethoprim-sulfamethoxazole. Ann Intern Med. 1987 Oct;107(4):600–600. doi: 10.7326/0003-4819-107-4-600_1. [DOI] [PubMed] [Google Scholar]
  10. BROCKMAN R. W. BIOCHEMICAL ASPECTS OF MERCAPTOPURINE INHBITION AND RESISTANCE. Cancer Res. 1963 Sep;23:1191–1201. [PubMed] [Google Scholar]
  11. Bagley C. M., Jr, Bostick F. W., DeVita V. T., Jr Clinical pharmacology of cyclophosphamide. Cancer Res. 1973 Feb;33(2):226–233. [PubMed] [Google Scholar]
  12. Baguley E., Hughes G. R. Antiendothelial cell antibodies. J Rheumatol. 1989 Jun;16(6):716–717. [PubMed] [Google Scholar]
  13. Baguley E., Hughes G. R. Lytic IgG anti-endothelial cell antibodies in vasculitis. Lancet. 1988 Oct 15;2(8616):907–907. doi: 10.1016/s0140-6736(88)92505-6. [DOI] [PubMed] [Google Scholar]
  14. Balow J. E., Austin H. A., 3rd, Muenz L. R., Joyce K. M., Antonovych T. T., Klippel J. H., Steinberg A. D., Plotz P. H., Decker J. L. Effect of treatment on the evolution of renal abnormalities in lupus nephritis. N Engl J Med. 1984 Aug 23;311(8):491–495. doi: 10.1056/NEJM198408233110802. [DOI] [PubMed] [Google Scholar]
  15. Bernard P., Arnaud M., Treves R., Bonnetblanc J. M. Dapsone and rheumatoid vasculitis leg ulcerations. J Am Acad Dermatol. 1988 Jan;18(1 Pt 1):140–141. doi: 10.1016/s0190-9622(88)80049-5. [DOI] [PubMed] [Google Scholar]
  16. Bertino J. R. Chemical action and pharmacology of methotrexate, azathioprine and cyclophosphamide in man. Arthritis Rheum. 1973 Jan-Feb;16(1):79–83. doi: 10.1002/art.1780160113. [DOI] [PubMed] [Google Scholar]
  17. Blackwell G. J., Carnuccio R., Di Rosa M., Flower R. J., Parente L., Persico P. Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature. 1980 Sep 11;287(5778):147–149. doi: 10.1038/287147a0. [DOI] [PubMed] [Google Scholar]
  18. Boom B. W., Brand A., Bavinck J. N., Eernisse J. G., Daha M. R., Vermeer B. J. Severe leukocytoclastic vasculitis of the skin in a patient with essential mixed cryoglobulinemia treated with high-dose gamma-globulin intravenously. Arch Dermatol. 1988 Oct;124(10):1550–1553. [PubMed] [Google Scholar]
  19. Boumpas D. T., Paliogianni F., Anastassiou E. D., Balow J. E. Glucocorticosteroid action on the immune system: molecular and cellular aspects. Clin Exp Rheumatol. 1991 Jul-Aug;9(4):413–423. [PubMed] [Google Scholar]
  20. Brandwein S., Esdaile J., Danoff D., Tannenbaum H. Wegener's granulomatosis. Clinical features and outcome in 13 patients. Arch Intern Med. 1983 Mar;143(3):476–479. doi: 10.1001/archinte.143.3.476. [DOI] [PubMed] [Google Scholar]
  21. Butler W. T., Rossen R. D. Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone. J Clin Invest. 1973 Oct;52(10):2629–2640. doi: 10.1172/JCI107455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Callen J. P., af Ekenstam E. Cutaneous leukocytoclastic vasculitis: clinical experience in 44 patients. South Med J. 1987 Jul;80(7):848–851. doi: 10.1097/00007611-198707000-00012. [DOI] [PubMed] [Google Scholar]
  23. Cameron J. S. Acute renal disease in vasculitis. Ann Med Interne (Paris) 1988;139(2):103–107. [PubMed] [Google Scholar]
  24. Cameron J. S., Turner D. R., Ogg C. S., Williams D. G., Lessof M. H., Chantler C., Leibowitz S. Systemic lupus with nephritis: a long-term study. Q J Med. 1979 Jan;48(189):1–24. [PubMed] [Google Scholar]
  25. Carette S., Klippel J. H., Decker J. L., Austin H. A., Plotz P. H., Steinberg A. D., Balow J. E. Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up. Ann Intern Med. 1983 Jul;99(1):1–8. doi: 10.7326/0003-4819-99-1-1. [DOI] [PubMed] [Google Scholar]
  26. Chow C. C., Li E. K., Lai F. M. Allergic granulomatosis and angiitis (Churg-Strauss syndrome): response to 'pulse' intravenous cyclophosphamide. Ann Rheum Dis. 1989 Jul;48(7):605–608. doi: 10.1136/ard.48.7.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Chumbley L. C., Harrison E. G., Jr, DeRemee R. A. Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc. 1977 Aug;52(8):477–484. [PubMed] [Google Scholar]
  28. Claman H. N. Corticosteroids and lymphoid cells. N Engl J Med. 1972 Aug 24;287(8):388–397. doi: 10.1056/NEJM197208242870806. [DOI] [PubMed] [Google Scholar]
  29. Clements P. J., Davis J. Cytotoxic drugs: their clinical application to the rheumatic diseases. Semin Arthritis Rheum. 1986 May;15(4):231–254. doi: 10.1016/0049-0172(86)90020-x. [DOI] [PubMed] [Google Scholar]
  30. Cohen R. D., Conn D. L., Ilstrup D. M. Clinical features, prognosis, and response to treatment in polyarteritis. Mayo Clin Proc. 1980 Mar;55(3):146–155. [PubMed] [Google Scholar]
  31. Conn D. L. Role of cyclophosphamide in treatment of polyarteritis nodosa? J Rheumatol. 1991 Apr;18(4):489–490. [PubMed] [Google Scholar]
  32. Conn D. L., Tompkins R. B., Nichols W. L. Glucocorticoids in the management of vasculitis--a double edged sword? J Rheumatol. 1988 Aug;15(8):1181–1183. [PubMed] [Google Scholar]
  33. Costanzo-Nordin M. R., O'Sullivan E. J., Hubbell E. A., Zucker M. J., Pifarre R., McManus B. M., Winters G. L., Scanlon P. J., Robinson J. A. Long-term follow-up of heart transplant recipients treated with murine antihuman mature T cell monoclonal antibody (OKT3): the Loyola experience. J Heart Transplant. 1989 Jul-Aug;8(4):288–295. [PubMed] [Google Scholar]
  34. Cupps T. R. Cyclophosphamide: to pulse or not to pulse? Am J Med. 1990 Oct;89(4):399–402. doi: 10.1016/0002-9343(90)90366-l. [DOI] [PubMed] [Google Scholar]
  35. Cupps T. R., Edgar L. C., Fauci A. S. Suppression of human B lymphocyte function by cyclophosphamide. J Immunol. 1982 Jun;128(6):2453–2457. [PubMed] [Google Scholar]
  36. Cupps T. R., Edgar L. C., Thomas C. A., Fauci A. S. Multiple mechanisms of B cell immunoregulation in man after administration of in vivo corticosteroids. J Immunol. 1984 Jan;132(1):170–175. [PubMed] [Google Scholar]
  37. DAMESHEK W., SCHWARTZ R. Treatment of certain "autoimmune" diseases with antimetabolites; a preliminary report. Trans Assoc Am Physicians. 1960;73:113–127. [PubMed] [Google Scholar]
  38. David D. S., Grieco M. H., Cushman P., Jr Adrenal glucocorticoids after twenty years. A review of their clinically relevant consequences. J Chronic Dis. 1970 Mar;22(10):637–711. doi: 10.1016/0021-9681(70)90078-0. [DOI] [PubMed] [Google Scholar]
  39. De Silva M., Hazleman B. L. Long-term azathioprine in rheumatoid arthritis: a double-blind study. Ann Rheum Dis. 1981 Dec;40(6):560–563. doi: 10.1136/ard.40.6.560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. De Vita S., Neri R., Bombardieri S. Cyclophosphamide pulses in the treatment of rheumatic diseases: an update. Clin Exp Rheumatol. 1991 Mar-Apr;9(2):179–193. [PubMed] [Google Scholar]
  41. DeRemee R. A., McDonald T. J., Weiland L. H. Wegener's granulomatosis: observations on treatment with antimicrobial agents. Mayo Clin Proc. 1985 Jan;60(1):27–32. doi: 10.1016/s0025-6196(12)65279-3. [DOI] [PubMed] [Google Scholar]
  42. DeRemee R. A. The treatment of Wegener's granulomatosis with trimethoprim/sulfamethoxazole: illusion or vision? Arthritis Rheum. 1988 Aug;31(8):1068–1074. doi: 10.1002/art.1780310821. [DOI] [PubMed] [Google Scholar]
  43. Dechant K. L., Brogden R. N., Pilkington T., Faulds D. Ifosfamide/mesna. A review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer. Drugs. 1991 Sep;42(3):428–467. doi: 10.2165/00003495-199142030-00006. [DOI] [PubMed] [Google Scholar]
  44. Delaney V. B., Campbell W. G., Jr, Nasr S. A., McCue P. A., Warshaw B., Whelchel J. D. Efficacy of OKT3 monoclonal antibody therapy in steroid-resistant, predominantly vascular acute rejection. A report of three cases with morphologic and immunophenotypic evaluation. Transplantation. 1988 Apr;45(4):743–748. doi: 10.1097/00007890-198804000-00016. [DOI] [PubMed] [Google Scholar]
  45. Delaney V. B., Fraley D. S., Segal D. P., Bruns F. J. Plasmapheresis as sole therapy in a patient with essential mixed cryoglobulinemia. Am J Kidney Dis. 1984 Jul;4(1):75–77. doi: 10.1016/s0272-6386(84)80031-1. [DOI] [PubMed] [Google Scholar]
  46. Dennis G., June C. H., Mizuguchi J., Ohara J., Witherspoon K., Finkelman F. D., McMillan V., Mond J. J. Glucocorticoids suppress calcium mobilization and phospholipid hydrolysis in anti-Ig antibody-stimulated B cells. J Immunol. 1987 Oct 15;139(8):2516–2523. [PubMed] [Google Scholar]
  47. FAHEY J. L., LEONARD E., CHURG J., GODMAN G. Wegener's granulomatosis. Am J Med. 1954 Aug;17(2):168–179. doi: 10.1016/0002-9343(54)90255-7. [DOI] [PubMed] [Google Scholar]
  48. Fauci A. S., Dale D. C. The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest. 1974 Jan;53(1):240–246. doi: 10.1172/JCI107544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Fauci A. S., Haynes B. F., Costa J., Katz P., Wolff S. M. Lymphomatoid Granulomatosis. Prospective clinical and therapeutic experience over 10 years. N Engl J Med. 1982 Jan 14;306(2):68–74. doi: 10.1056/NEJM198201143060203. [DOI] [PubMed] [Google Scholar]
  50. Fauci A. S., Haynes B. F., Katz P., Wolff S. M. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 1983 Jan;98(1):76–85. doi: 10.7326/0003-4819-98-1-76. [DOI] [PubMed] [Google Scholar]
  51. Fauci A. S., Haynes B., Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med. 1978 Nov;89(5 Pt 1):660–676. doi: 10.7326/0003-4819-89-5-660. [DOI] [PubMed] [Google Scholar]
  52. Fauci A. S., Katz P., Haynes B. F., Wolff S. M. Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med. 1979 Aug 2;301(5):235–238. doi: 10.1056/NEJM197908023010503. [DOI] [PubMed] [Google Scholar]
  53. Fauci A. S. Mechanisms of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function. Clin Exp Immunol. 1976 Apr;24(1):54–62. [PMC free article] [PubMed] [Google Scholar]
  54. Felson D. T., Anderson J. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis. N Engl J Med. 1984 Dec 13;311(24):1528–1533. doi: 10.1056/NEJM198412133112402. [DOI] [PubMed] [Google Scholar]
  55. Fernandez-Herlihy L. Duration of corticosteroid therapy in giant cell arteritis. J Rheumatol. 1980 May-Jun;7(3):361–364. [PubMed] [Google Scholar]
  56. Fondevila Carlos G., Milone Gustavo A., Santiago P. Cutaneous vasculitis after intermediate dose of methotrexate (IDMTX). Br J Haematol. 1989 Aug;72(4):591–592. doi: 10.1111/j.1365-2141.1989.tb04330.x. [DOI] [PubMed] [Google Scholar]
  57. Fort J. G., Abruzzo J. L. Reversal of progressive necrotizing vasculitis with intravenous pulse cyclophosphamide and methylprednisolone. Arthritis Rheum. 1988 Sep;31(9):1194–1198. doi: 10.1002/art.1780310918. [DOI] [PubMed] [Google Scholar]
  58. Fortson J. S., Zone J. J., Hammond M. E., Groggel G. C. Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone. J Am Acad Dermatol. 1986 Nov;15(5 Pt 2):1137–1142. doi: 10.1016/s0190-9622(86)70282-x. [DOI] [PubMed] [Google Scholar]
  59. Fraga A., Mintz G., Valle L., Flores-Izquierdo G. Takayasu's arteritis: frequency of systemic manifestations (study of 22 patients) and favorable response to maintenance steroid therapy with adrenocorticosteroids (12 patients). Arthritis Rheum. 1972 Nov-Dec;15(6):617–624. doi: 10.1002/art.1780150608. [DOI] [PubMed] [Google Scholar]
  60. Fredenberg M. F., Malkinson F. D. Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases. J Am Acad Dermatol. 1987 Apr;16(4):772–778. doi: 10.1016/s0190-9622(87)70100-5. [DOI] [PubMed] [Google Scholar]
  61. Fries L. F., Brickman C. M., Frank M. M. Monocyte receptors for the Fc portion of IgG increase in number in autoimmune hemolytic anemia and other hemolytic states and are decreased by glucocorticoid therapy. J Immunol. 1983 Sep;131(3):1240–1245. [PubMed] [Google Scholar]
  62. Frohnert P. P., Sheps S. G. Long-term follow-up study of periarteritis nodosa. Am J Med. 1967 Jul;43(1):8–14. doi: 10.1016/0002-9343(67)90144-1. [DOI] [PubMed] [Google Scholar]
  63. Fuiano G., Cameron J. S., Raftery M., Hartley B. H., Williams D. G., Ogg C. S. Improved prognosis of renal microscopic polyarteritis in recent years. Nephrol Dial Transplant. 1988;3(4):383–391. doi: 10.1093/oxfordjournals.ndt.a091685. [DOI] [PubMed] [Google Scholar]
  64. Fuiano G., Cameron J. S., Raftery M., Hartley B. H., Williams D. G., Ogg C. S. Improved prognosis of renal microscopic polyarteritis in recent years. Nephrol Dial Transplant. 1988;3(4):383–391. doi: 10.1093/oxfordjournals.ndt.a091685. [DOI] [PubMed] [Google Scholar]
  65. Furusho K., Kamiya T., Nakano H., Kiyosawa N., Shinomiya K., Hayashidera T., Tamura T., Hirose O., Manabe Y., Yokoyama T. High-dose intravenous gammaglobulin for Kawasaki disease. Lancet. 1984 Nov 10;2(8411):1055–1058. doi: 10.1016/s0140-6736(84)91504-6. [DOI] [PubMed] [Google Scholar]
  66. Galland R. B., Spencer J. Natural history and surgical management of radiation enteritis. Br J Surg. 1987 Aug;74(8):742–747. doi: 10.1002/bjs.1800740833. [DOI] [PubMed] [Google Scholar]
  67. Gassmann A. E., van Furth R. The effect of azathioprine (Imuran) on the kinetics of monocytes and macrophages during the normal steady state and an acute inflammatory reaction. Blood. 1975 Jul;46(1):51–64. [PubMed] [Google Scholar]
  68. Geltner D., Kohn R. W., Gorevic P., Franklin E. C. The effect of combination therapy (steroids, immunosuppressives, and plasmapheresis) on 5 mixed cryoglobulinemia patients with renal, neurologic, and vascular involvement. Arthritis Rheum. 1981 Sep;24(9):1121–1127. doi: 10.1002/art.1780240902. [DOI] [PubMed] [Google Scholar]
  69. Geltner D. Therapeutic approaches in mixed cryoglobulinemia. Springer Semin Immunopathol. 1988;10(1):103–113. doi: 10.1007/BF02054027. [DOI] [PubMed] [Google Scholar]
  70. Gillis S., Crabtree G. R., Smith K. A. Glucocorticoid-induced inhibition of T cell growth factor production. II. The effect on the in vitro generation of cytolytic T cells. J Immunol. 1979 Oct;123(4):1632–1638. [PubMed] [Google Scholar]
  71. Goodwin J. S., Atluru D. Mechanism of action of glucocorticoid-induced immunoglobulin production: role of lipoxygenase metabolites of arachidonic acid. J Immunol. 1986 May 1;136(9):3455–3460. [PubMed] [Google Scholar]
  72. Graham E., Holland A., Avery A., Russell R. W. Prognosis in giant-cell arteritis. Br Med J (Clin Res Ed) 1981 Jan 24;282(6260):269–271. doi: 10.1136/bmj.282.6260.269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Gray R. E., Doherty S. M., Galloway J., Coulton L., de Broe M., Kanis J. A. A double-blind study of deflazacort and prednisone in patients with chronic inflammatory disorders. Arthritis Rheum. 1991 Mar;34(3):287–295. doi: 10.1002/art.1780340306. [DOI] [PubMed] [Google Scholar]
  74. Groothuis D. R., Mikhael M. A. Focal cerebral vasculitis associated with circulating immune complexes and brain irradiation. Ann Neurol. 1986 Jun;19(6):590–592. doi: 10.1002/ana.410190612. [DOI] [PubMed] [Google Scholar]
  75. Guillevin L., Jarrousse B., Lok C., Lhote F., Jais J. P., Le Thi Huong Du D., Bussel A. Longterm followup after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. The Cooperative Study Group for Polyarteritis Nodosa. J Rheumatol. 1991 Apr;18(4):567–574. [PubMed] [Google Scholar]
  76. Hall S., Barr W., Lie J. T., Stanson A. W., Kazmier F. J., Hunder G. G. Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore) 1985 Mar;64(2):89–99. [PubMed] [Google Scholar]
  77. Herrmann F., Schulz G., Wieser M., Kolbe K., Nicolay U., Noack M., Lindemann A., Mertelsmann R. Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy. Am J Med. 1990 Jun;88(6):619–624. doi: 10.1016/0002-9343(90)90528-l. [DOI] [PubMed] [Google Scholar]
  78. Hirata F., Schiffmann E., Venkatasubramanian K., Salomon D., Axelrod J. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci U S A. 1980 May;77(5):2533–2536. doi: 10.1073/pnas.77.5.2533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Hoffbrand B. I. Dapsone in Henoch-Schönlein purpura--worth a trial. Postgrad Med J. 1991 Nov;67(793):961–962. doi: 10.1136/pgmj.67.793.961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Hollander D., Manning R. T. The use of alkylating agents in the treatment of Wegener's granulomatosis. Ann Intern Med. 1967 Aug;67(2):393–398. doi: 10.7326/0003-4819-67-2-393. [DOI] [PubMed] [Google Scholar]
  81. Holtman J. H., Neustadt D. H., Klein J., Callen J. P. Dapsone is an effective therapy for the skin lesions of subacute cutaneous lupus erythematosus and urticarial vasculitis in a patient with C2 deficiency. J Rheumatol. 1990 Sep;17(9):1222–1225. [PubMed] [Google Scholar]
  82. Horneff G., Burmester G. R., Emmrich F., Kalden J. R. Treatment of rheumatoid arthritis with an anti-CD4 monoclonal antibody. Arthritis Rheum. 1991 Feb;34(2):129–140. doi: 10.1002/art.1780340202. [DOI] [PubMed] [Google Scholar]
  83. Hunder G. G., Arend W. P., Bloch D. A., Calabrese L. H., Fauci A. S., Fries J. F., Leavitt R. Y., Lie J. T., Lightfoot R. W., Jr, Masi A. T. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum. 1990 Aug;33(8):1065–1067. doi: 10.1002/art.1780330802. [DOI] [PubMed] [Google Scholar]
  84. Hunder G. G., Lie J. T. The vasculitides. Cardiovasc Clin. 1983;13(2):261–291. [PubMed] [Google Scholar]
  85. Hurd E. R., Giuliano V. J. The effect of cyclophosphamide on B and T lymphocytes in patients with connective tissue diseases. Arthritis Rheum. 1975 Jan-Feb;18(1):67–75. doi: 10.1002/art.1780180113. [DOI] [PubMed] [Google Scholar]
  86. Huskisson E. C. Azathioprine. Clin Rheum Dis. 1984 Aug;10(2):325–332. [PubMed] [Google Scholar]
  87. Irvine R. F. How is the level of free arachidonic acid controlled in mammalian cells? Biochem J. 1982 Apr 15;204(1):3–16. doi: 10.1042/bj2040003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Isreal H. L., Patchfsky A. S. Treatment of Wegener's granulomatosis of lung. Am J Med. 1975 May;58(5):671–673. doi: 10.1016/0002-9343(75)90503-3. [DOI] [PubMed] [Google Scholar]
  89. Jayne D. R., Davies M. J., Fox C. J., Black C. M., Lockwood C. M. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet. 1991 May 11;337(8750):1137–1139. doi: 10.1016/0140-6736(91)92797-6. [DOI] [PubMed] [Google Scholar]
  90. Jeurissen M. E., Boerbooms A. M., van de Putte L. B. Eruption of nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis. Clin Rheumatol. 1989 Sep;8(3):417–419. doi: 10.1007/BF02030360. [DOI] [PubMed] [Google Scholar]
  91. Joseph G., Holtman J. S., Kosfeld R. E., Blodgett W. A., Liu Y. K. Pregnancy in Henoch-Schönlein purpura. Am J Obstet Gynecol. 1987 Oct;157(4 Pt 1):911–912. doi: 10.1016/s0002-9378(87)80087-x. [DOI] [PubMed] [Google Scholar]
  92. Kauffmann R. H., Houwert D. A. Plasmapheresis in rapidly progressive Henoch-Schoenlein glomerulonephritis and the effect on circulating IgA immune complexes. Clin Nephrol. 1981 Sep;16(3):155–160. [PubMed] [Google Scholar]
  93. Kaveri S. V., Dietrich G., Hurez V., Kazatchkine M. D. Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases. Clin Exp Immunol. 1991 Nov;86(2):192–198. doi: 10.1111/j.1365-2249.1991.tb05794.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Kern J. A., Lamb R. J., Reed J. C., Daniele R. P., Nowell P. C. Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms. J Clin Invest. 1988 Jan;81(1):237–244. doi: 10.1172/JCI113301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  95. Kyle V., Hazleman B. L. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months. Ann Rheum Dis. 1989 Aug;48(8):658–661. doi: 10.1136/ard.48.8.658. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Kyle V., Hazleman B. L. Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects. Ann Rheum Dis. 1989 Aug;48(8):662–666. doi: 10.1136/ard.48.8.662. [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Lanham J. G., Elkon K. B., Pusey C. D., Hughes G. R. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984 Mar;63(2):65–81. doi: 10.1097/00005792-198403000-00001. [DOI] [PubMed] [Google Scholar]
  98. Leavitt R. Y., Fauci A. S. Pulmonary vasculitis. Am Rev Respir Dis. 1986 Jul;134(1):149–166. doi: 10.1164/arrd.1986.134.1.149. [DOI] [PubMed] [Google Scholar]
  99. Leavitt R. Y., Hoffman G. S., Fauci A. S. The role of trimethoprim/sulfamethoxazole in the treatment of Wegener's granulomatosis. Arthritis Rheum. 1988 Aug;31(8):1073–1074. doi: 10.1002/art.1780310822. [DOI] [PubMed] [Google Scholar]
  100. Leib E. S., Restivo C., Paulus H. E. Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med. 1979 Dec;67(6):941–947. doi: 10.1016/0002-9343(79)90634-x. [DOI] [PubMed] [Google Scholar]
  101. Leung D. Y., Collins T., Lapierre L. A., Geha R. S., Pober J. S. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest. 1986 May;77(5):1428–1435. doi: 10.1172/JCI112454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Levy J., Barnett E. V., MacDonald N. S., Klinenberg J. R., Pearson C. M. The effect of azathioprine on gammaglobulin synthesis in man. J Clin Invest. 1972 Sep;51(9):2233–2238. doi: 10.1172/JCI107031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Liebow A. A., Carrington C. R., Friedman P. J. Lymphomatoid granulomatosis. Hum Pathol. 1972 Dec;3(4):457–558. doi: 10.1016/s0046-8177(72)80005-4. [DOI] [PubMed] [Google Scholar]
  104. Locht H., Lindström F. D. Wegener's granulomatosis: treatment failure on conventional therapy. J Rheumatol. 1989 Apr;16(4):544–546. [PubMed] [Google Scholar]
  105. Lockwood C. M., Pinching A. J., Sweny P., Rees A. J., Pussell B., Uff J., Peters D. K. Plasma-exchange and immunosuppression in the treatment of fulminating immune-complex crescentic nephritis. Lancet. 1977 Jan 8;1(8002):63–67. doi: 10.1016/s0140-6736(77)91079-0. [DOI] [PubMed] [Google Scholar]
  106. Lupi-Herrera E., Sánchez-Torres G., Marcushamer J., Mispireta J., Horwitz S., Vela J. E. Takayasu's arteritis. Clinical study of 107 cases. Am Heart J. 1977 Jan;93(1):94–103. doi: 10.1016/s0002-8703(77)80178-6. [DOI] [PubMed] [Google Scholar]
  107. Luqmani R. A., Palmer R. G., Bacon P. A. Azathioprine, cyclophosphamide and chlorambucil. Baillieres Clin Rheumatol. 1990 Dec;4(3):595–619. doi: 10.1016/s0950-3579(05)80009-3. [DOI] [PubMed] [Google Scholar]
  108. Löw A., Hotze A., Krapf F., Schranz W., Manger B. J., Mahlstedt J., Wolf F., Kalden J. R. The nonspecific clearance function of the reticuloendothelial system in patients with immune complex mediated diseases before and after therapeutic plasmapheresis. Rheumatol Int. 1985;5(2):69–72. doi: 10.1007/BF00270299. [DOI] [PubMed] [Google Scholar]
  109. Mac Gregor R. R. Granulocyte adherence changes induced by hemodialysis, endotoxin, epinephrine, and glucocorticoids. Ann Intern Med. 1977 Jan;86(1):35–39. doi: 10.7326/0003-4819-86-1-35. [DOI] [PubMed] [Google Scholar]
  110. MacFadyen R., Tron V., Keshmiri M., Road J. D. Allergic angiitis of Churg and Strauss syndrome. Response to pulse methylprednisolone. Chest. 1987 Apr;91(4):629–631. doi: 10.1378/chest.91.4.629. [DOI] [PubMed] [Google Scholar]
  111. Manger B. J., Krapf F. E., Gramatzki M., Nüsslein H. G., Burmester G. R., Krauledat P. B., Kalden J. R. IgE-containing circulating immune complexes in Churg-Strauss vasculitis. Scand J Immunol. 1985 Apr;21(4):369–373. doi: 10.1111/j.1365-3083.1985.tb01443.x. [DOI] [PubMed] [Google Scholar]
  112. Mathieson P. W., Cobbold S. P., Hale G., Clark M. R., Oliveira D. B., Lockwood C. M., Waldmann H. Monoclonal-antibody therapy in systemic vasculitis. N Engl J Med. 1990 Jul 26;323(4):250–254. doi: 10.1056/NEJM199007263230407. [DOI] [PubMed] [Google Scholar]
  113. Navarro M., Pedragosa R., Lafuerza A., Rubio D., Huguet P. Leukocytoclastic vasculitis after high-dose methotrexate. Ann Intern Med. 1986 Sep;105(3):471–472. doi: 10.7326/0003-4819-105-3-471_3. [DOI] [PubMed] [Google Scholar]
  114. Newburger J. W., Takahashi M., Beiser A. S., Burns J. C., Bastian J., Chung K. J., Colan S. D., Duffy C. E., Fulton D. R., Glode M. P. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991 Jun 6;324(23):1633–1639. doi: 10.1056/NEJM199106063242305. [DOI] [PubMed] [Google Scholar]
  115. Newburger J. W., Takahashi M., Burns J. C., Beiser A. S., Chung K. J., Duffy C. E., Glode M. P., Mason W. H., Reddy V., Sanders S. P. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 1986 Aug 7;315(6):341–347. doi: 10.1056/NEJM198608073150601. [DOI] [PubMed] [Google Scholar]
  116. Nicholls A., Snaith M. L., Maini R. N., Scott J. T. Proceedings: Controlled trial of azathioprine in rheumatoid vasculitis. Ann Rheum Dis. 1973 Nov;32(6):589–591. doi: 10.1136/ard.32.6.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  117. Novack S. N., Pearson C. M. Cyclophosphamide therapy in Wegener's granulomatosis. N Engl J Med. 1971 Apr 29;284(17):938–942. doi: 10.1056/NEJM197104292841703. [DOI] [PubMed] [Google Scholar]
  118. O'Duffy J. D., Robertson D. M., Goldstein N. P. Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet's disease. Am J Med. 1984 Jan;76(1):75–84. doi: 10.1016/0002-9343(84)90753-8. [DOI] [PubMed] [Google Scholar]
  119. Oster W., Herrmann F., Cicco A., Gamm H., Zeile G., Brune T., Lindemann A., Schulz G., Mertelsmann R. Erythropoietin prevents chemotherapy-induced anemia: case report. Blut. 1990 Feb;60(2):88–92. doi: 10.1007/BF01720513. [DOI] [PubMed] [Google Scholar]
  120. Paavonen T. Glucocorticoids enhance the in vitro Ig synthesis of pokeweed mitogen-stimulated human B cells by inhibiting the suppressive effect of T8+ T cells. Scand J Immunol. 1985 Jan;21(1):63–71. doi: 10.1111/j.1365-3083.1985.tb01404.x. [DOI] [PubMed] [Google Scholar]
  121. Parrillo J. E., Fauci A. S. Mechanisms of glucocorticoid action on immune processes. Annu Rev Pharmacol Toxicol. 1979;19:179–201. doi: 10.1146/annurev.pa.19.040179.001143. [DOI] [PubMed] [Google Scholar]
  122. Petersen J. Essential cryoglobulinaemia: a clinical course lasting 25 years. Scand J Haematol. 1985 Nov;35(5):501–504. doi: 10.1111/j.1600-0609.1985.tb02819.x. [DOI] [PubMed] [Google Scholar]
  123. Petru E., Schmähl D. Anticancer drugs: second malignancies--risk reduction. Cancer Treat Rev. 1987 Dec;14(3-4):337–343. doi: 10.1016/0305-7372(87)90027-2. [DOI] [PubMed] [Google Scholar]
  124. Pinching A. J., Rees A. J., Pussell B. A., Lockwood C. M., Mitchison R. S., Peters D. K. Relapses in Wegener's granulomatosis: the role of infection. Br Med J. 1980 Sep 27;281(6244):836–838. doi: 10.1136/bmj.281.6244.836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Plotnick S., Huppert A. S., Kantor G. Colchicine and leukocytoclastic vasculitis. Arthritis Rheum. 1989 Nov;32(11):1489–1490. doi: 10.1002/anr.1780321125. [DOI] [PubMed] [Google Scholar]
  126. Riechmann L., Clark M., Waldmann H., Winter G. Reshaping human antibodies for therapy. Nature. 1988 Mar 24;332(6162):323–327. doi: 10.1038/332323a0. [DOI] [PubMed] [Google Scholar]
  127. Rinehart J. J., Sagone A. L., Balcerzak S. P., Ackerman G. A., LoBuglio A. F. Effects of corticosteroid therapy on human monocyte function. N Engl J Med. 1975 Jan 30;292(5):236–241. doi: 10.1056/NEJM197501302920504. [DOI] [PubMed] [Google Scholar]
  128. Sakamoto H., Takaoka T., Usami M., Emura M., Okabe K., Matsushita M., Smith J. W., Malchesky P. S., Nose Y. Apheresis: clinical response to patients unresponsive to conventional therapy. Trans Am Soc Artif Intern Organs. 1985;31:704–710. [PubMed] [Google Scholar]
  129. Sanchez de Toledo Codina J., Rodriguez Galindo C., Moraga Llop F., Fernandez-Balbuena C. N., Giralt Lopez J. Response of central nervous system vasculitis to irradiation. Lancet. 1991 May 4;337(8749):1105–1106. doi: 10.1016/0140-6736(91)91761-i. [DOI] [PubMed] [Google Scholar]
  130. Schlansky R., DeHoratius R. J., Pincus T., Tung K. S. Plasmapheresis in systemic lupus erythematosus: a cautionary note. Arthritis Rheum. 1981 Jan;24(1):49–53. doi: 10.1002/art.1780240108. [DOI] [PubMed] [Google Scholar]
  131. Schneider H. A., Yonker R. A., Katz P., Longley S., Panush R. S. Rheumatoid vasculitis: experience with 13 patients and review of the literature. Semin Arthritis Rheum. 1985 May;14(4):280–286. doi: 10.1016/0049-0172(85)90047-2. [DOI] [PubMed] [Google Scholar]
  132. Schreiber A. D., Parsons J., McDermott P., Cooper R. A. Effect of corticosteroids on the human monocyte IgG and complement receptors. J Clin Invest. 1975 Nov;56(5):1189–1197. doi: 10.1172/JCI108196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Scott D. G., Bacon P. A., Elliott P. J., Tribe C. R., Wallington T. B. Systemic vasculitis in a district general hospital 1972-1980: clinical and laboratory features, classification and prognosis of 80 cases. Q J Med. 1982 Summer;51(203):292–311. [PubMed] [Google Scholar]
  134. Scott D. G., Bacon P. A. Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. Am J Med. 1984 Mar;76(3):377–384. doi: 10.1016/0002-9343(84)90654-5. [DOI] [PubMed] [Google Scholar]
  135. Segal R., Caspi D., Tishler M., Fishel B., Yaron M. Accelerated nodulosis and vasculitis during methotrexate therapy for rheumatoid arthritis. Arthritis Rheum. 1988 Sep;31(9):1182–1185. doi: 10.1002/art.1780310915. [DOI] [PubMed] [Google Scholar]
  136. Shaw I. C., Graham M. I. Mesna--a short review. Cancer Treat Rev. 1987 Jun;14(2):67–86. doi: 10.1016/0305-7372(87)90041-7. [DOI] [PubMed] [Google Scholar]
  137. Shelhamer J. H., Volkman D. J., Parrillo J. E., Lawley T. J., Johnston M. R., Fauci A. S. Takayasu's arteritis and its therapy. Ann Intern Med. 1985 Jul;103(1):121–126. doi: 10.7326/0003-4819-103-1-121. [DOI] [PubMed] [Google Scholar]
  138. Sladek N. E. Therapeutic efficacy of cyclophosphamide as a function of its metabolism. Cancer Res. 1972 Mar;32(3):535–542. [PubMed] [Google Scholar]
  139. Smith K. A. T-cell growth factor. Immunol Rev. 1980;51:337–357. doi: 10.1111/j.1600-065x.1980.tb00327.x. [DOI] [PubMed] [Google Scholar]
  140. Spann C. R., Callen J. P., Yam L. T., Apgar J. T. Cutaneous leukocytoclastic vasculitis complicating hairy cell leukemia (leukemic reticuloendotheliosis). Arch Dermatol. 1986 Sep;122(9):1057–1059. [PubMed] [Google Scholar]
  141. Sultan Y., Kazatchkine M. D., Maisonneuve P., Nydegger U. E. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet. 1984 Oct 6;2(8406):765–768. doi: 10.1016/s0140-6736(84)90701-3. [DOI] [PubMed] [Google Scholar]
  142. Tabbara K. F. Chlorambucil in Behçet's disease. A reappraisal. Ophthalmology. 1983 Aug;90(8):906–908. doi: 10.1016/s0161-6420(83)80014-1. [DOI] [PubMed] [Google Scholar]
  143. Tidd D. M., Paterson A. R. A biochemical mechanism for the delayed cytotoxic reaction of 6-mercaptopurine. Cancer Res. 1974 Apr;34(4):738–746. [PubMed] [Google Scholar]
  144. Turk J. L., Poulter L. W. Selective depletion of lymphoid tissue by cyclophosphamide. Clin Exp Immunol. 1972 Feb;10(2):285–296. [PMC free article] [PubMed] [Google Scholar]
  145. Upchurch K. S., Heller K., Bress N. M. Low-dose methotrexate therapy for cutaneous vasculitis of rheumatoid arthritis. J Am Acad Dermatol. 1987 Aug;17(2 Pt 2):355–359. doi: 10.1016/s0190-9622(87)70212-6. [DOI] [PubMed] [Google Scholar]
  146. WALTON E. W. Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J. 1958 Aug 2;2(5091):265–270. doi: 10.1136/bmj.2.5091.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  147. Ware A. J., Luby J. P., Hollinger B., Eigenbrodt E. H., Cuthbert J. A., Atkins C. R., Shorey J., Hull A. R., Combes B. Etiology of liver disease in renal-transplant patients. Ann Intern Med. 1979 Sep;91(3):364–371. doi: 10.7326/0003-4819-91-3-364. [DOI] [PubMed] [Google Scholar]
  148. Werni R., Schwarz T., Gschnait F. Colchicine treatment of urticarial vasculitis. Dermatologica. 1986;172(1):36–40. doi: 10.1159/000249290. [DOI] [PubMed] [Google Scholar]
  149. West B. C., Todd J. R., King J. W. Wegener granulomatosis and trimethoprim-sulfamethoxazole. Complete remission after a twenty-year course. Ann Intern Med. 1987 Jun;106(6):840–842. doi: 10.7326/0003-4819-106-6-840. [DOI] [PubMed] [Google Scholar]
  150. Williams H. C., Pembroke A. C. Methotrexate in the treatment of vasculitic cutaneous ulceration in rheumatoid arthritis. J R Soc Med. 1989 Dec;82(12):763–763. [PMC free article] [PubMed] [Google Scholar]
  151. Winkelstein A., Starz T. W., Agarwal A. Efficacy of combined therapy with plasmapheresis and immunosuppressants in rheumatoid vasculitis. J Rheumatol. 1984 Apr;11(2):162–166. [PubMed] [Google Scholar]
  152. Wofsy D., Chiang N. Y., Greenspan J. S., Ermak T. H. Treatment of murine lupus with monoclonal antibody to L3T4. I. Effects on the distribution and function of lymphocyte subsets and on the histopathology of autoimmune disease. J Autoimmun. 1988 Oct;1(5):415–431. doi: 10.1016/0896-8411(88)90065-0. [DOI] [PubMed] [Google Scholar]
  153. Wolff S. M., Fauci A. S., Horn R. G., Dale D. C. Wegener's granulomatosis. Ann Intern Med. 1974 Oct;81(4):513–525. doi: 10.7326/0003-4819-81-4-513. [DOI] [PubMed] [Google Scholar]
  154. Wysenbeek A. J., Calabrese L. H., Mandel D. R., Clough J. D. Limited plasmapheresis in fulminant leukocytoclastic vasculitis. J Rheumatol. 1982 Mar-Apr;9(2):315–318. [PubMed] [Google Scholar]
  155. Yazici H., Pazarli H., Barnes C. G., Tüzün Y., Ozyazgan Y., Silman A., Serdaroğlu S., Oğuz V., Yurdakul S., Lovatt G. E. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med. 1990 Feb 1;322(5):281–285. doi: 10.1056/NEJM199002013220501. [DOI] [PubMed] [Google Scholar]
  156. Yuasa K., Tokitsu M., Goto H., Kato H., Shimada K. Wegener's granulomatosis: diagnosis by transbronchial lung biopsy, evaluation by gallium scintigraphy and treatment with sulfamethoxazole/trimethoprim. Am J Med. 1988 Feb;84(2):371–372. doi: 10.1016/0002-9343(88)90450-0. [DOI] [PubMed] [Google Scholar]
  157. Yy D. T., Clements P. J., Peter J. B., Levy J., Paulus H. E., Barnett E. V. Lymphocyte characteristics in rheumatic patients and the effect of azathioprine therapy. Arthritis Rheum. 1974 Jan-Feb;17(1):37–45. doi: 10.1002/art.1780170107. [DOI] [PubMed] [Google Scholar]
  158. ZEEK P. M. Periarteritis nodosa; a critical review. Am J Clin Pathol. 1952 Aug;22(8):777–790. doi: 10.1093/ajcp/22.8.777. [DOI] [PubMed] [Google Scholar]
  159. Zhu L. P., Cupps T. R., Whalen G., Fauci A. S. Selective effects of cyclophosphamide therapy on activation, proliferation, and differentiation of human B cells. J Clin Invest. 1987 Apr;79(4):1082–1090. doi: 10.1172/JCI112922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  160. Ziegler E. J., Fisher C. J., Jr, Sprung C. L., Straube R. C., Sadoff J. C., Foulke G. E., Wortel C. H., Fink M. P., Dellinger R. P., Teng N. N. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med. 1991 Feb 14;324(7):429–436. doi: 10.1056/NEJM199102143240701. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES